Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition and links to updates and FAQs, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T17:32:49.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-17T17:09:26.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T18:10:33.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and a minimal header, replacing the previously visible study details, locations, and associated documents.
    Difference
    18%
    Check dated 2026-09-19T21:53:06.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    An NIH funding note for 2019 was added to the study record. The revision tag was updated from v3.6.5 to v3.6.6, indicating an updated administrative entry.
    Difference
    0.0%
    Check dated 2026-08-29T18:30:16.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a new release of the document set. This is a metadata update that does not alter visible page content.
    Difference
    0.0%
    Check dated 2026-08-08T08:27:32.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.